intellectual disability, autosomal dominant 15

Rare Disease

MONDO:0013820

Also known as:

COFFIN-SIRIS syndrome 3CSS3Coffin-Siris syndrome caused by mutation in SMARCB1

Any Coffin-Siris syndrome in which the cause of the disease is a mutation in the SMARCB1 gene.

Genes

Clinical Trials

–

Newborn Screening

–

Patient Groups

–

Patient-Friendly Information

Comprehensive, easy-to-understand information about this condition

How we create this content →

Report Generation Failed

We couldn't automatically generate the report. This may be due to temporary service issues.

Companies Active in intellectual disability, autosomal dominant 15

0 approved

Organizations with approved therapies for this disease

No approved therapies yet

Research is ongoing — 2 companies have orphan drug designations for this disease

BridgeBio Pharma, Inc.

Other

Designated

FoldRx Pharmaceuticals, Inc., a subsidiary of Pfizer Inc.

Other

Designated

View all companies active in intellectual disability, autosomal dominant 15

Need this data in your product?

Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.

Explore API Start Free

← Back to All Diseases